SCHEMBL19281145

SCHEMBL19281145

[2H]C([2H])([2H])OCC1CC2(CCN(C(=O)c3ccc(C(C)(C)O)cc3)CC2)Oc2cc(F)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.39
EPHX1 P07099 1/20 0.39
CYP2C9 P11712 1/20 0.39
ACACB O00763 8/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
ACACA Q13085 2/20 0.34
TP53 P04637 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
MAPK1 P28482 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19281152 0.81 ACACB (0.39) ACACBALDH1A1TSHRCYP2D6
SCHEMBL12695080 0.77 EPHX2 (0.45) EPHX2EPHX1CYP2C9ACACBHDAC3
SCHEMBL12481973 0.75 HTR2C (0.37) CYP2D6
SCHEMBL19281150 0.71 ACACB (0.40) ACACBALDH1A1
SCHEMBL12695157 0.70 CYP2D6 (0.36) EPHX2EPHX1CYP2C9ACACBACACA
SCHEMBL12695139 0.70 CYP2D6 (0.36) EPHX2EPHX1CYP2C9ACACBACACA
SCHEMBL12695128 0.70 CYP2D6 (0.36) EPHX2EPHX1CYP2C9ACACBACACA
SCHEMBL12695125 0.69 EPHX2 (0.47) EPHX2EPHX1CYP2C9ACACBHDAC3
SCHEMBL12695141 0.67 EPHX2 (0.37) EPHX2EPHX1CYP2C9ACACBTRPM8
SCHEMBL12695165 0.66 ACACB (0.40) EPHX2EPHX1ACACBUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675812-B1 CHROMAN - SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2017-08-30 EP disclosed